TTR and Alzheimer disease: Increased production of TTR in neurons exposed to Abeta1–42 toxicity, and reduced levels of the protein in blood [22], [23] and CSF [24]–[26] indicate an involvement of TTR (dys)function in clearance deficits as they occur in AD.